XML 37 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Stock Option Plan and Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of Significant Assumptions The significant assumptions used in these calculations are summarized as follows:
Three Months Ended March 31,
20222021
Expected term (in years)
5.8 - 6.1
5.5 - 6.6
Expected volatility
109.0% - 110.0%
92.0% - 94.2%
Expected dividend rate0.0 %0.0 %
Risk free interest rate
1.73% - 2.42%
0.53% - 0.73%
Stock price
$3.78 - $4.24
$7.56 - $10.00
Schedule of Stock Option Activity
The following table summarizes option award activity during the three months ended March 31, 2022:
Number of Stock Option AwardsWeighted Average Exercise PriceWeighted Average Remaining Contractual Life (Years)Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 2021
8,550,076 $4.66 
Granted1,948,998 $3.83 
Exercised(153,570)$1.02 
Forfeited(374,257)$8.34 
Outstanding as of March 31, 2022
9,971,247 $4.41 8.8$16,544 
Options vested and expected to vest as of March 31, 2022
9,971,247 $4.41 
Vested and exercisable at March 31, 2022
2,759,100 $3.01 7.8$7,569 
Schedule of Stock Based Compensation Expense
The following sets forth the total stock-based compensation expense for the Company’s stock options included in the Company’s condensed consolidated statement of operations:
Three Months Ended March 31,
(in thousands)20222021
Research and development$867 $497 
General and administrative1,243 839 
Total stock-based compensation expense$2,110 $1,336